|
New England Pharmaceuticals News. Service for global professionals. Constantly updated news and information about New England Pharmaceuticals.
Latest New England Pharmaceuticals News
- Business letters to the editor (11/21/2009) 23 Nov 2009 05:50 GMT
... plans.'" Since when has the health insurance industry been responsible for "innovation," other than making ... insurance industry, much less that of the pharmaceutical industry. If they are not serving the ... airports in the Northeast (such as Bangor, Maine; Bar Harbor, Maine; Hartford, Conn; or New Haven, Conn., ...
- RXi Pharmaceuticals Wins 2009 RNAi Technology Innovation of the Year Award from Frost & Sullivan 23 Nov 2009 12:50 GMT
... RXi Pharmaceuticals Wins 2009 RNAi Technology Innovation of the ... © 2009, NewsBlaze, Tags: Healthcare, Business wire, massachusetts, Health, Biotechnology, Pharmaceuticals RXi Pharmaceuticals Wins 2009 ...
- Nereus Pharmaceuticals Presents Positive Interim Data from the ADVANCE Study, a Randomized Phase 2 Clinical Trial of Pli 23 Nov 2009 14:10 GMT
... Nereus Pharmaceuticals Presents Positive Interim Data from the ADVANCE ... Targets and Cancer Therapeutics meeting in Boston, Massachusetts by the lead author Dr. Rebecca Heist, ...
- Lobbying is up as health industry examines impact of reform proposals 23 Nov 2009 16:51 GMT
... health care reform bill (Hernandez, 11/22). : The Pharmaceutical Research and Manufacturers of America is continuing ... such as Alaska, Arkansas, Colorado, Indiana, Louisiana, Maine, Montana, Nebraska, Nevada, North Carolina, North Dakota and ... published for . Copyright 2009 Advisory Board Company and ...
- Nereus Pharmaceuticals Presents Positive Interim Data from the ADVANCE Study, a Randomized Phase 2 Clinical Trial of Plinabulin (NPI-2358) in Non-Small Cell Lung Cancer at the 2009 EORTC-NCI-AACR Conf 23 Nov 2009 13:30 GMT
... SAN DIEGO--(BUSINESS WIRE)-- Nereus Pharmaceuticals, Inc., a pioneer in drug discovery from ... Targets and Cancer Therapeutics meeting in Boston, Massachusetts by the lead author Dr. Rebecca Heist, ...
- Nereus Pharmaceuticals Presents Positive Interim Data from the ADVANCE Study, a Randomized Phase 2 Clinical Trial of Plinabulin (NPI-2358) in Non-Small Cell Lung Cancer at the 2009 EORTC-NCI-AACR Conference 23 Nov 2009 13:30 GMT
... Nereus Pharmaceuticals Presents Positive Interim Data from the ADVANCE ... Targets and Cancer Therapeutics meeting in Boston, Massachusetts by the lead author Dr. Rebecca Heist, ...
- KINAXO Completes Financing Round for Biomarker Development 23 Nov 2009 14:32 GMT
... KINAXO Completes Financing Round for Biomarker Development Martinsried, Germany, ... be one of the major drivers of pharmaceutical research and development in the 21st Century. ... held positions at Harvard Medical School, the Massachusetts General Hospital and Merck Sharp & Dohme. ...
- ZOLL LifeVest Presented at AHA Scientific Sessions 2009 23 Nov 2009 20:22 GMT
... ZOLL LifeVest Presented at AHA Scientific Sessions 2009 CHELMSFORD, ... the United States, in California, Colorado, Illinois, Massachusetts, Pennsylvania, and Rhode Island. More than 400 direct sales and service ...
- BUYINS.NET: DCGN, TTGT, GRAN Expected To Be Lower After Earnings Releases on Wednesday 23 Nov 2009 17:27 GMT
... Nov 23, 2009 (M2 PRESSWIRE via COMTEX) -- BUYINS.NET / www.squeezetrigger.com ... exists. deCODE genetics, Inc. (NASDAQ: DCGN), a bio-pharmaceutical company, develops and markets products for the ... in 1999 and is headquartered in Needham, Massachusetts. Bank of Granite Corporation (NASDAQ: GRAN) operates ...
- KINAXO Completes Financing Round To Enhance Biomarker Development 23 Nov 2009 12:51 GMT
... KINAXO Completes Financing Round To Enhance Biomarker Development Martinsried, ... be one of the major drivers of pharmaceutical research and development in the 21st Century. ... held positions at Harvard Medical School, the Massachusetts General Hospital and Merck Sharp & Dohme. ...
- Interim Data from a Clinical Trial Evaluating GI Dynamics' EndoBarrier Gastrointestinal Liner in Patients with Type 2 D 23 Nov 2009 14:10 GMT
... Interim Data from a Clinical Trial Evaluating GI Dynamics' EndoBarrier ... of metabolic treatment options that fit between pharmaceutical regimens and surgery, called non-surgical therapeutics. Non-surgical ... loss on these efforts. Based in Lexington, Massachusetts and founded in 2003, GI Dynamics is ...
- Pearl Therapeutics Appoints Howie Rosen to Board of Directors 23 Nov 2009 14:01 GMT
... Pearl Therapeutics Appoints Howie Rosen to Board of Directors ... 23 /PRNewswire/ -- Pearl Therapeutics Inc., a biopharmaceutical company developing therapeutic products for the treatment ... an M.S. in chemical engineering from the Massachusetts Institute of Technology, and a B.S. in ...
- Constellation's CSO and Scientific Advisor Receive Medal of Honor from American Cancer Society 23 Nov 2009 14:31 GMT
... Constellation's CSO and Scientific Advisor Receive Medal of ... for Outstanding Contributions in Cancer Research )--Constellation Pharmaceuticals, Inc., today announced that the American Cancer ... he served as Scientific Director for the Massachusetts General Hospital Cancer Center and as Associate ...
- Interim Data from a Clinical Trial Evaluating GI Dynamics' EndoBarrier'˘ Gastrointestinal Liner in Patients with Type 2 Diabetes Presented at GASTRO 2009 23 Nov 2009 14:16 GMT
... Interim Data from a Clinical Trial Evaluating GI Dynamics’ EndoBarrier™ ... of metabolic treatment options that fit between pharmaceutical regimens and surgery, called non-surgical therapeutics. Non-surgical ... loss on these efforts. Based in Lexington, Massachusetts and founded in 2003, GI Dynamics is ...
- Gene Silencing To Boost Biological Drug Yields 23 Nov 2009 10:50 GMT
... An American biotech company is planning to use a new ... containing cultured lines of living cells. Alnylam Pharmaceuticals of Cambridge, Massachusetts is setting up a new venture called ...
Powered by 
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>> | |
|
a digital news provider
>
All New England News sections
latimes.com:
washingtonpost.com:
wsj.com:
cnn.com:
telegraph.co.uk:
cbsnews.com: